https://www.dfat.gov.auc.unnite/thenaliagiaguagroupsnet/siten/tdex.tmll <
Thierry Roisnel, Yoshihiro Tsujimoto, Masaki Morita, Yasuto Noda, Yuuki Mogami, Atsushi Kitada, Masatoshi Ohkura, Saburo Hosokawa, Zhaofei Li, Katsuro Hayashi, Yoshihiro Kusano, Jung eun Kim, Naruki Tsuji, Akihiko Fujiwara,Yoshitaka Matsushita,Kazuyoshi Yoshimura,Kiyonori Takegoshi,Masashi Inoue,Mikio takano和Hiroshi Kageyama*,“ Batio3的氧气含量Huo,Xianyu Xu,Zhi LV,Jiaqing Song*,Mingyuan He,Zhaofei li,
引用:Kazunori Nakase,Hiroshi Miwa和Yoshihiro Miyahara。(2025)。表面白血病干细胞标记的临床意义:
这项工作得到了(i)为日本促进科学研究奖学金协会(Kakenhi Kiban A,S。Kurosawa)授予的赠款(ii)高级测量和分析开发计划(Sentan),日本科学技术机构(JST),(JST),(JST),(ii)通过目标技术转移计划,(ii)通过目标技术转移计划(jurs)(kure and-ders-ders&d)(s。项目旨在促进地震,经济,贸易和工业部(METI),(V)支持行业计划,Meti和(VI)新化学技术进步协会的创新。此外,我们要感谢以下人员的支持:Yoshihihiro Nakamura先生在多学科高级材料研究所(IMRAM),TOHOKU UNIVESRION和MURAKAMI YOSHIHIRO先生,Hiroshi Uemura先生,Hiroshi Uemura先生,Megumi Toguchi女士和Megumi Sasaki in Imr。
根据pTIS-3N0M0肺腺癌Masaoki ITO中的组织学亚型和肿瘤侵袭状态的EGFR和KRAS突变的分布和预后影响; Miyata Yoshihiro; Kei Kushitani; ueda daisuke; Yukio Takeshima; Morihito冈田。广岛大学辐射生物学和医学研究所外科肿瘤学系,1 − 2- 3 Kasumi,Minami -ku,734 − 8551 — 8551 Hiroshima,日本。广岛大学生物医学与健康科学研究生院,1 − 2- 3 Kasumi,Minami -ku,734 -85551 Hiroshima,日本。
[Participants] [Number of Speakers] 5 Toshimitsu Taiko Director, President & CEO, Representative Executive Officer Noriyasu Kuzuhara Director, Executive Vice President & Executive Officer Responsible for Industry Business Yoshihiro Hirai Executive Vice President & Executive Officer Responsible for Corporate Accounting, Corporate Finance, Legal, Risk Management and Compliance Miwa Okamura Senior Vice President & Executive Officer Responsible for Corporate Communications and IR Takahiko Ueno投资者关系经理[分析师名称]* Masahiro Shibano Citigroup全球市场
冠状动脉介入治疗·药物洗脱支架植入后血流储备分数和冠状动脉血流储备的预后意义 Hiroki Ueno、Masahiro Hoshino、Eisuke Usui、Tomoyo Sugiyama、Yoshihisa Kanaji、Masahiro Hada、Toru Misawa、Tatsuhiro Nagamine、Yoshihiro Hanyu、Kai Nogami、Kodai Sayama、Kazuki Matsuda、Tatsuya Sakamoto、Taishi Yonetsu、Tetsuo Sasano、Tsunekazu Kakuta ········· 853 社论 支架植入后的冠状动脉血流储备能否成为靶血管衰竭的有用预测指标? Hirohiko Ando,Carlos Collet,Tetsuya Amano·······860·吸收GT1可生物可吸收的血管脚手架系统 - 日本的5年后市场监视研究 - Nakamura Masato Nakamura Tomohiro Sakamoto,Kengo Tanabe,Hajime Kusano,Kelly A. Stockelman,Ken kozuma·kozuma············· ELET治疗,然后在可生物降解的聚合物洗脱支架植入后进行P2Y 12抑制剂单一疗法 - REIWA地区范围范围内注册表 - Masaru Ishida,Ryutaro Shimada,Fumiaki Takahashi,Takahashi田口、大崎卓也、西山修、远藤宏、坂本良平、田中健太郎、小枝依彦、木村匠、后藤岩男、二宫亮、佐佐木涉、伊藤友德、森野义弘、令和会调查员代表 ········· 876
Yoshihiro Hosoya,Hosoya PE办公室Kengo Ishige,Ihi Co. Dong-Ying Ju,Saitama技术研究所Yuuji Kimura,国家材料科学研究所Manabu Kubota,Nippon Steel Co.钢铁有限公司,Ihi机械和炉子有限公司在雷吉·萨卡塔(Reiji Sakata) Co.,Ltd。Toshiyuki Shimazaki,Shimazaki Netsushori Co. Ltd. Masaaki Sugiyama,日本热处理学会Manabu Takahashi,Kyushu University shin-ichi University shin-ichi takahi takahashi Yamamoto,丰田汽车公司东京技术研究所Aki Kodai大学Satoru Kobayashi,川崎重工业有限公司。
微生物参与环境清理toru kyomen tkyomen@ ・固态化学和功能氧化物的设计kiichi sato kiichi.sato@ sato@ ・开发微生物分析系统Soshi shiraishi shiraishi shiraishi soshishiraishi soshishiraishi3 y-sumiyoshi@ ・ Studies on molecular structures of transient species and complexes consisting of radicals Masashi Sonoyama sonoyama@ ・ Biomolecular science, Biophysical chemistry of proteins, Biospectroscopy, Bioinformatics Hiroshi Takahashi hirotakahashi@ ・ Structural analysis and thermal study of model biomembranes Shigeki Takeda stakeda@・受体的功能分析,蛋白质自组装的表征和应用Nakamura Nakamura@@新型π共轭系统的结构和特性,包括